TNF-Alpha Inhibition for Treatment of Alzheimer's Disease
Status:
Completed
Trial end date:
2006-01-01
Target enrollment:
Participant gender:
Summary
It is widely believed that inflammation contributes to the pathogenesis of AD. TNF has been
implicated in both AD and neurological inflammation. Anti-TNF therapy is therefore surmised
to be of potential benefit for treating AD.